AmphiStar funding news – Belgian-based AmphiStar Received a €2 Million Non-Dilutive Grant from SPRIN-D
Oct 21, 2024 | By Team SR
Biotech startup AmphiStar, a leader in sustainable surfactant products, has recently been awarded a €2 million non-dilutive grant from SPRIN-D (Federal Agency for Disruptive Innovation).
SUMMARY
- Biotech startup AmphiStar, a leader in sustainable surfactant products, has recently been awarded a €2 million funding
- AmphiStar leads the circular economy with innovative biotechnology, creating sustainable, high-performance products for personal care, home care, and industrial sectors.
This brings the total funding secured by the Belgian innovator to €10 million this year. AmphiStar’s biotechnology platform utilizes synthetic biology to develop custom molecules that meet specific performance requirements.
These tailor-made biosurfactants, derived from organic waste and side streams, not only provide an environmentally friendly alternative to conventional chemically produced surfactants (fossil- and biobased) and other commercial microbial biosurfactants, but also open up new opportunities for innovation in the cleaning, cosmetics, and personal care industries.
RECOMMENDED FOR YOU
SAIZ funding news – Berlin-based SAIZ Raises €2.5 Million in Seed Funding
Team SR
Jul 18, 2024
The grant is part of a highly competitive multi-stage funding program supported by the German government, and it will aid in furthering the development of AmphiStar's advanced biotechnology platform. Previously, the company received €1.5 million in the program’s initial phase last year and is currently in the running for an additional €2 million in the final round of funding, which will be awarded next year to the top two performing teams.
Pierre-Franck Valentin, CEO of AmphiStar, said, "With the freedom that non-dilutive funding provides, we can continue to develop and refine our bespoke, sustainable surfactants that meet the growing demand for high-performance, eco-friendly solutions in personal- and home care. This support reinforces the German government’s recognition of our breakthrough technology and its potential to revolutionize the industry."
Sophie Roelants, Co-founder and COO of AmphiStar, said, "This grant enables us to concentrate on developing entirely new, promising molecules at low technology readiness levels (TRL), all produced from waste through a continuous biomanufacturing process. Our goal is to reduce costs and enhance sustainability while maintaining functionality, aligning perfectly with our mission to replace traditional surfactants with environmentally responsible, bio-based alternatives — without compromising on quality or affordability."
About AmphiStar
AmphiStar leads the circular economy with innovative biotechnology, creating sustainable, high-performance products for personal care, home care, and industrial sectors.